We are live on ! Find out more
RVMDW icon

Revolution Medicines Inc Warrant
RVMDW

24 hedge funds and large institutions have $1.5M invested in Revolution Medicines Inc Warrant in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

9% more funds holding

Funds holding: 22 → 24 (+2)

0.31% less ownership

Funds ownership: 4.5% → 4.19% (-0.31%)

21% less capital invested

Capital invested by funds: $1.89M → $1.5M (-$394K)

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
24
Holders Change
+2
Holders Change %
+9.09%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
4
Closed
1
Calls
$18.8M
Puts
–
Net Calls
+$18.8M
Net Calls Change
+$4.36M

Top Buyers

Rank Fund Capital Flow
1
LP
LMR Partners
United Kingdom
+$442K
2
Citadel Advisors
Citadel Advisors
Florida
+$6.82K
3
CL
CSS LLC
Illinois
+$602
4
CA
CoreCap Advisors
Michigan
+$20

Top Sellers

Rank Fund Capital Flow
1
Walleye Capital
Walleye Capital
New York
-$48.4K
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$210
3
UBS Group
UBS Group
Switzerland
-$178
4
TWC
TD Waterhouse Canada
Ontario, Canada
-$133
5
CAC
Cowen and Company
New York
-$20
Name Holding Trade Value Shares
Change 		Change in
Stake
LP
1
LMR Partners
United Kingdom
$399K +$442K +2,185,658 New
BFM
2
Boothbay Fund Management
New York
$262K – – –
D.E. Shaw & Co
3
D.E. Shaw & Co
New York
$216K – – –
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$98K -$210 -1,038 -0.2%
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$91.3K – – –
SCM
6
Soros Capital Management
New York
$66.6K – – –
Walleye Capital
7
Walleye Capital
New York
$65.1K -$48.4K -239,319 -40%
PA
8
Perceptive Advisors
New York
$45.6K – – –
BL
9
Bleichroeder LP
New York
$36.5K – – –
CAC
10
Cowen and Company
New York
$36.5K -$20 -100 -0.1%
SC
11
Sculptor Capital
New York
$33.8K – – –
DKCM
12
Davidson Kempner Capital Management
New York
$28.5K – – –
CL
13
CSS LLC
Illinois
$24.4K +$602 +2,975 +25%
MF
14
Magnetar Financial
Illinois
$22.2K – – –
FCM
15
Farallon Capital Management
California
$19.2K – – –
DIM
16
DLK Investment Management
California
$14.1K – – –
WAM
17
Wolverine Asset Management
Illinois
$12.8K – – –
WAM
18
Weiss Asset Management
Massachusetts
$11.8K – – –
TD Asset Management
19
TD Asset Management
Ontario, Canada
$6.5K – – –
Citadel Advisors
20
Citadel Advisors
Florida
$5.4K +$6.82K +33,722 New
TYCC
21
Texas Yale Capital Corp
Florida
$1.82K – – –
CA
22
CoreCap Advisors
Michigan
$18 +$20 +100 New
UBS Group
23
UBS Group
Switzerland
$17 -$178 -880 -91%
TWC
24
TD Waterhouse Canada
Ontario, Canada
– -$133 -448 Closed

RVMDW Hedge Fund Activity: Q1 2024 in Review

24 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Revolution Medicines Inc Warrant (RVMDW) for Q1 2024, worth a combined $1.5M — down 21% from $1.89M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new RVMDW positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 4 trimmed.

The largest buyer was LMR Partners, opening a new position worth an estimated $442K. The largest seller was Walleye Capital, cutting an estimated $48.4K.

  • 24 institutional investors held Revolution Medicines Inc Warrant (RVMDW) as of Q1 2024, up from 22 in Q4 2023.
  • Funds reported $1.5M of Revolution Medicines Inc Warrant stock for Q1 2024, down 21% quarter-over-quarter.
  • 3 funds opened new Revolution Medicines Inc Warrant positions in Q1 2024 and 1 closed out, a net change of +2 holders.
  • The largest Revolution Medicines Inc Warrant buyer in Q1 2024 was LMR Partners, an estimated $442K added.
  • The largest Revolution Medicines Inc Warrant seller in Q1 2024 was Walleye Capital, an estimated $48.4K sold.

Based on aggregated 13F filings for Q1 2024.